nVerses Capital LLC Buys Shares of 8,900 Veralto Co. (NYSE:VLTO)

nVerses Capital LLC bought a new stake in shares of Veralto Co. (NYSE:VLTO) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 8,900 shares of the company’s stock, valued at approximately $996,000.

Other large investors also recently added to or reduced their stakes in the company. Goodman Advisory Group LLC purchased a new position in shares of Veralto during the 2nd quarter valued at $26,000. LRI Investments LLC bought a new stake in Veralto in the first quarter worth $30,000. Fairscale Capital LLC bought a new stake in Veralto in the second quarter worth $30,000. Newbridge Financial Services Group Inc. bought a new stake in Veralto during the fourth quarter valued at about $32,000. Finally, Hazlett Burt & Watson Inc. raised its position in shares of Veralto by 11,100.0% during the second quarter. Hazlett Burt & Watson Inc. now owns 336 shares of the company’s stock valued at $32,000 after buying an additional 333 shares during the last quarter. 91.28% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on VLTO. TD Cowen upped their price objective on shares of Veralto from $95.00 to $100.00 and gave the company a “hold” rating in a research report on Tuesday, July 30th. Robert W. Baird upped their price objective on shares of Veralto from $98.00 to $112.00 and gave the company a “neutral” rating in a research report on Monday, July 29th. The Goldman Sachs Group upped their price objective on shares of Veralto from $104.00 to $116.00 and gave the company a “buy” rating in a research report on Monday, July 29th. BMO Capital Markets upped their price objective on shares of Veralto from $117.00 to $119.00 and gave the company an “outperform” rating in a research report on Monday, September 30th. Finally, Stifel Nicolaus upped their price objective on shares of Veralto from $117.00 to $119.00 and gave the company a “buy” rating in a research report on Wednesday. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $108.00.

Veralto Trading Up 0.3 %

VLTO traded up $0.33 during mid-day trading on Thursday, hitting $112.85. The stock had a trading volume of 152,230 shares, compared to its average volume of 1,539,914. The stock’s fifty day simple moving average is $110.39 and its 200-day simple moving average is $101.71. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.96 and a quick ratio of 1.70. The firm has a market capitalization of $27.86 billion and a price-to-earnings ratio of 35.27. Veralto Co. has a 1-year low of $65.51 and a 1-year high of $114.61.

Veralto (NYSE:VLTO) last posted its earnings results on Thursday, July 25th. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.05. The company had revenue of $1.29 billion for the quarter, compared to analyst estimates of $1.28 billion. Veralto had a net margin of 15.60% and a return on equity of 58.82%. The business’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period last year, the business posted $0.80 earnings per share. As a group, research analysts forecast that Veralto Co. will post 3.45 EPS for the current fiscal year.

Veralto Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Friday, September 27th will be given a $0.09 dividend. This represents a $0.36 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend is Friday, September 27th. Veralto’s dividend payout ratio (DPR) is presently 11.29%.

Insider Activity

In other news, CEO Jennifer Honeycutt sold 13,191 shares of Veralto stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $111.98, for a total value of $1,477,128.18. Following the completion of the transaction, the chief executive officer now owns 138,546 shares of the company’s stock, valued at $15,514,381.08. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other Veralto news, SVP Surekha Trivedi sold 753 shares of Veralto stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $112.55, for a total value of $84,750.15. Following the completion of the sale, the senior vice president now owns 11,165 shares in the company, valued at $1,256,620.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jennifer Honeycutt sold 13,191 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $111.98, for a total transaction of $1,477,128.18. Following the completion of the transaction, the chief executive officer now owns 138,546 shares of the company’s stock, valued at $15,514,381.08. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,039 shares of company stock valued at $4,310,335 in the last quarter. Company insiders own 0.31% of the company’s stock.

Veralto Company Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.